BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14516774)

  • 1. Tissue-specific regulation of checkpoint kinase 2 expression by p53.
    Chin MY; Li G
    Exp Mol Pathol; 2003 Oct; 75(2):131-6. PubMed ID: 14516774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific regulation of Chk1 expression by p53.
    Cheung KJ; Li G
    Exp Mol Pathol; 2001 Oct; 71(2):156-60. PubMed ID: 11599922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific regulation of Fas/APO-1/CD95 expression by p53.
    Lin P; Bush JA; Cheung KJ; Li G
    Int J Oncol; 2002 Aug; 21(2):261-4. PubMed ID: 12118319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Chk2 tumor suppressor is not required for p53 responses in human cancer cells.
    Jallepalli PV; Lengauer C; Vogelstein B; Bunz F
    J Biol Chem; 2003 Jun; 278(23):20475-9. PubMed ID: 12654917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of CHK2 in human gastric carcinomas harboring p53 mutations.
    Shigeishi H; Yokozaki H; Oue N; Kuniyasu H; Kondo T; Ishikawa T; Yasui W
    Int J Cancer; 2002 May; 99(1):58-62. PubMed ID: 11948492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1.
    Yu Q; La Rose J; Zhang H; Takemura H; Kohn KW; Pommier Y
    Cancer Res; 2002 Oct; 62(20):5743-8. PubMed ID: 12384533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chk2 is required for optimal mitotic delay in response to irradiation-induced DNA damage incurred in G2 phase.
    Rainey MD; Black EJ; Zachos G; Gillespie DA
    Oncogene; 2008 Feb; 27(7):896-906. PubMed ID: 17684483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Questioning the role of checkpoint kinase 2 in the p53 DNA damage response.
    Ahn J; Urist M; Prives C
    J Biol Chem; 2003 Jun; 278(23):20480-9. PubMed ID: 12654916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect on retardation of G2/M phase in esophageal carcinoma cells transfected with CHK1 and CHK2 shRNA after irradiation].
    Wang YX; Zhu SC; Feng W; Li J; Su JW; Li R
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):572-7. PubMed ID: 17236549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription.
    Takai H; Naka K; Okada Y; Watanabe M; Harada N; Saito S; Anderson CW; Appella E; Nakanishi M; Suzuki H; Nagashima K; Sawa H; Ikeda K; Motoyama N
    EMBO J; 2002 Oct; 21(19):5195-205. PubMed ID: 12356735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo.
    Niida H; Murata K; Shimada M; Ogawa K; Ohta K; Suzuki K; Fujigaki H; Khaw AK; Banerjee B; Hande MP; Miyamoto T; Miyoshi I; Shirai T; Motoyama N; Delhase M; Appella E; Nakanishi M
    EMBO J; 2010 Oct; 29(20):3558-70. PubMed ID: 20834228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium Fluoride Arrests Renal G2/M Phase Cell-Cycle Progression by Activating ATM-Chk2-P53/Cdc25C Signaling Pathway in Mice.
    Luo Q; Guo H; Kuang P; Cui H; Deng H; Liu H; Lu Y; Wei Q; Chen L; Fang J; Zuo Z; Deng J; Li Y; Wang X; Zhao L
    Cell Physiol Biochem; 2018; 51(5):2421-2433. PubMed ID: 30537743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage-induced activation of p53 by the checkpoint kinase Chk2.
    Hirao A; Kong YY; Matsuoka S; Wakeham A; Ruland J; Yoshida H; Liu D; Elledge SJ; Mak TW
    Science; 2000 Mar; 287(5459):1824-7. PubMed ID: 10710310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response.
    Jack MT; Woo RA; Hirao A; Cheung A; Mak TW; Lee PW
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9825-9. PubMed ID: 12097646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.
    Chehab NH; Malikzay A; Appel M; Halazonetis TD
    Genes Dev; 2000 Feb; 14(3):278-88. PubMed ID: 10673500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 down-regulates CHK1 through p21 and the retinoblastoma protein.
    Gottifredi V; Karni-Schmidt O; Shieh SS; Prives C
    Mol Cell Biol; 2001 Feb; 21(4):1066-76. PubMed ID: 11158294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.
    Falck J; Lukas C; Protopopova M; Lukas J; Selivanova G; Bartek J
    Oncogene; 2001 Sep; 20(39):5503-10. PubMed ID: 11571648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation.
    Ou YH; Chung PH; Sun TP; Shieh SY
    Mol Biol Cell; 2005 Apr; 16(4):1684-95. PubMed ID: 15659650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of RNA interference on CHK1 and CHK2 expression and G2/M arrest in esophageal carcinoma cell line TE13 after irradiation].
    Zhu SC; Wang YX; Li R; Han C; Qiu R; Shen WB
    Ai Zheng; 2007 Feb; 26(2):127-31. PubMed ID: 17298739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.